MA52937A - Composés inhibiteurs d'oga - Google Patents

Composés inhibiteurs d'oga

Info

Publication number
MA52937A
MA52937A MA052937A MA52937A MA52937A MA 52937 A MA52937 A MA 52937A MA 052937 A MA052937 A MA 052937A MA 52937 A MA52937 A MA 52937A MA 52937 A MA52937 A MA 52937A
Authority
MA
Morocco
Prior art keywords
inhibitor compounds
oga inhibitor
oga
compounds
inhibitor
Prior art date
Application number
MA052937A
Other languages
English (en)
Inventor
José Manuel Bartolomé-Nebreda
Susana Conde-Ceide
Lucas Olivares Ana Isabel De
Francisca Delgado-Jiménez
Andrés Avelino Trabanco-Suárez
Ramiro Juan Antonio Vega
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA52937A publication Critical patent/MA52937A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MA052937A 2018-06-20 2019-06-20 Composés inhibiteurs d'oga MA52937A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18382449 2018-06-20

Publications (1)

Publication Number Publication Date
MA52937A true MA52937A (fr) 2021-04-28

Family

ID=62784076

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052937A MA52937A (fr) 2018-06-20 2019-06-20 Composés inhibiteurs d'oga

Country Status (9)

Country Link
US (1) US20210122763A1 (fr)
EP (1) EP3810612A1 (fr)
JP (1) JP2021527663A (fr)
CN (1) CN112292381A (fr)
AU (1) AU2019289971A1 (fr)
CA (1) CA3103758A1 (fr)
MA (1) MA52937A (fr)
TW (1) TW202016118A (fr)
WO (1) WO2019243530A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020509004A (ja) * 2017-02-27 2020-03-26 ヤンセン ファーマシューティカ エヌ．ベー． Ｏｇａ阻害剤としての、ピペリジン、モルホリンまたはピペラジンで置換されている［１，２，４］−トリアゾロ［１，５−ａ］−ピリミジニル誘導体
CN113368243A (zh) * 2021-06-07 2021-09-10 中国人民解放军军事科学院军事医学研究院 髓母细胞瘤的治疗靶点及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA53944A (fr) * 2014-08-28 2021-08-25 Asceneuron Sa Inhibiteurs de la glycosidase
EP3419971B1 (fr) * 2016-02-25 2022-04-20 Asceneuron SA Inhibiteurs de glycosidases
EP3555087A1 (fr) * 2016-12-16 2019-10-23 Janssen Pharmaceutica NV Composés inhibiteurs d'oga monocyclique
WO2019037860A1 (fr) * 2017-08-24 2019-02-28 Asceneuron S.A. Inhibiteurs linéaires de la glycosidase

Also Published As

Publication number Publication date
US20210122763A1 (en) 2021-04-29
TW202016118A (zh) 2020-05-01
CN112292381A (zh) 2021-01-29
CA3103758A1 (fr) 2019-12-26
WO2019243530A1 (fr) 2019-12-26
EP3810612A1 (fr) 2021-04-28
AU2019289971A1 (en) 2020-12-17
JP2021527663A (ja) 2021-10-14

Similar Documents

Publication Publication Date Title
MA52942A (fr) Composés inhibiteurs d'oga
MA52939A (fr) Composés inhibiteurs d'oga
MA47575A (fr) Composés inhibiteurs d'oga monocyclique
MA47576A (fr) Composés inhibiteurs d'oga bicyclique
MA47420A (fr) Composés inhibiteurs d'oga
MA52486A (fr) Pyridazinones utilisés en tant qu'inhibiteurs de parp7
MA52948A (fr) Composés
MA52489A (fr) Nouveaux composés
MA44725A (fr) Formulations d'un inhibiteur de lsd1
MA51669A (fr) Composés
MA52967A (fr) Composés antagonistes du pcsk9
MA51616A (fr) Inhibiteurs d'adn-pk
MA53003A (fr) Composés
ES2982030T3 (es) Compuesto multiaziridínico
MA52004A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase
UA42295S (uk) Комп'ютер
MA46652A (fr) Polythérapie pour l'inhibition de c3
MA46242A (fr) Composés inhibiteurs de bêta-lactamase
MA54521A (fr) Dérivés d'oxopyridine substitués
UA42369S (uk) Комп'ютер
MA49006A (fr) Inhibiteurs d'ip6k
DK3737677T3 (da) Tetrahydroisoquinolinforbindelser
MA52935A (fr) Composés inhibiteurs d'oga
MA52946A (fr) Composés
DK3840596T3 (da) Sammensætning